Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13957887 [patent_doc_number] => 20190055287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => POLYPEPTIDE, DNA MOLECULE ENCODING THE POLYPEPTIDE, VECTOR, PREPARATION METHOD AND USE [patent_app_type] => utility [patent_app_number] => 16/178499 [patent_app_country] => US [patent_app_date] => 2018-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14570 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178499 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/178499
Polypeptide, DNA molecule encoding the polypeptide, vector, preparation method and use Oct 31, 2018 Issued
Array ( [id] => 17905511 [patent_doc_number] => 11459355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Peptides having octopus octopressin activity and use thereof [patent_app_type] => utility [patent_app_number] => 17/058528 [patent_app_country] => US [patent_app_date] => 2018-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5931 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058528 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/058528
Peptides having octopus octopressin activity and use thereof Oct 23, 2018 Issued
Array ( [id] => 16375122 [patent_doc_number] => 20200323964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MRNA [patent_app_type] => utility [patent_app_number] => 16/756442 [patent_app_country] => US [patent_app_date] => 2018-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 124086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756442 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/756442
PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MRNA Oct 14, 2018 Abandoned
Array ( [id] => 14132335 [patent_doc_number] => 20190100557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-04 [patent_title] => PROTRANSDUZIN B, A GENE TRANSFER ENHANCER [patent_app_type] => utility [patent_app_number] => 16/159900 [patent_app_country] => US [patent_app_date] => 2018-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1978 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159900 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/159900
PROTRANSDUZIN B, A GENE TRANSFER ENHANCER Oct 14, 2018 Abandoned
Array ( [id] => 14072325 [patent_doc_number] => 20190085050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => POLYPEPTIDES AND USES THEREOF FOR REDUCING CD95-MEDIATED CELL MOTILITY [patent_app_type] => utility [patent_app_number] => 16/156521 [patent_app_country] => US [patent_app_date] => 2018-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21108 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16156521 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/156521
Polypeptides and uses thereof for reducing CD95-mediated cell motility Oct 9, 2018 Issued
Array ( [id] => 14624585 [patent_doc_number] => 20190225660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS [patent_app_type] => utility [patent_app_number] => 16/150020 [patent_app_country] => US [patent_app_date] => 2018-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10514 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150020 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/150020
METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS Oct 1, 2018 Abandoned
Array ( [id] => 15711181 [patent_doc_number] => 20200102356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants [patent_app_type] => utility [patent_app_number] => 16/148848 [patent_app_country] => US [patent_app_date] => 2018-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148848 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/148848
Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants Sep 30, 2018 Pending
Array ( [id] => 13826557 [patent_doc_number] => 20190016763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => Fibroin-Like Protein Variant and Cell Culture Method [patent_app_type] => utility [patent_app_number] => 16/144562 [patent_app_country] => US [patent_app_date] => 2018-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16144562 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/144562
Fibroin-Like Protein Variant and Cell Culture Method Sep 26, 2018 Abandoned
Array ( [id] => 17467690 [patent_doc_number] => 11274158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-15 [patent_title] => Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators [patent_app_type] => utility [patent_app_number] => 16/140224 [patent_app_country] => US [patent_app_date] => 2018-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44073 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16140224 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/140224
Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators Sep 23, 2018 Issued
Array ( [id] => 19258052 [patent_doc_number] => 12018096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Potent peptide inhibitors of protein aggregation [patent_app_type] => utility [patent_app_number] => 16/647149 [patent_app_country] => US [patent_app_date] => 2018-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3774 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647149 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/647149
Potent peptide inhibitors of protein aggregation Sep 19, 2018 Issued
Array ( [id] => 16253515 [patent_doc_number] => 20200262889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => SUCCINATE-BINDING POLYPEPTIDES AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/647945 [patent_app_country] => US [patent_app_date] => 2018-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19624 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647945 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/647945
Succinate-binding polypeptides and use thereof Sep 17, 2018 Issued
Array ( [id] => 16296286 [patent_doc_number] => 20200282009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => METHODS OF TREATING DISEASES ASSOCIATED WITH VASCULAR SMOOTH MUSCLE CELL PROLIFERATION [patent_app_type] => utility [patent_app_number] => 16/646594 [patent_app_country] => US [patent_app_date] => 2018-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646594 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/646594
METHODS OF TREATING DISEASES ASSOCIATED WITH VASCULAR SMOOTH MUSCLE CELL PROLIFERATION Sep 11, 2018 Abandoned
Array ( [id] => 14258827 [patent_doc_number] => 10278957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-07 [patent_title] => Opioid agonist peptides and uses thereof [patent_app_type] => utility [patent_app_number] => 16/128352 [patent_app_country] => US [patent_app_date] => 2018-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 28563 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16128352 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/128352
Opioid agonist peptides and uses thereof Sep 10, 2018 Issued
Array ( [id] => 13733185 [patent_doc_number] => 20180371060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF) PEPTIDES AND USES THEREOF FOR TREATING NEOVASCULAR DISEASES, INFLAMMATORY DISEASES, CANCER, AND FOR CYTOPROTECTION [patent_app_type] => utility [patent_app_number] => 16/123863 [patent_app_country] => US [patent_app_date] => 2018-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18904 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 443 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123863 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/123863
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection Sep 5, 2018 Issued
Array ( [id] => 14277203 [patent_doc_number] => 20190135886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => GIP-GLP-1 DUAL AGONIST COMPOUNDS AND METHODS [patent_app_type] => utility [patent_app_number] => 16/121745 [patent_app_country] => US [patent_app_date] => 2018-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17587 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121745 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/121745
GIP-GLP-1 DUAL AGONIST COMPOUNDS AND METHODS Sep 4, 2018 Abandoned
Array ( [id] => 13733961 [patent_doc_number] => 20180371448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY [patent_app_type] => utility [patent_app_number] => 16/120156 [patent_app_country] => US [patent_app_date] => 2018-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5813 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16120156 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/120156
MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY Aug 30, 2018 Abandoned
Array ( [id] => 16437102 [patent_doc_number] => 20200354428 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-11-12 [patent_title] => ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES [patent_app_type] => utility [patent_app_number] => 16/109114 [patent_app_country] => US [patent_app_date] => 2018-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109114 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/109114
ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES Aug 21, 2018 Abandoned
Array ( [id] => 16437102 [patent_doc_number] => 20200354428 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-11-12 [patent_title] => ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES [patent_app_type] => utility [patent_app_number] => 16/109114 [patent_app_country] => US [patent_app_date] => 2018-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109114 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/109114
ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES Aug 21, 2018 Abandoned
Array ( [id] => 17133629 [patent_doc_number] => 11135163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-05 [patent_title] => Peptide hydrogel properties and its applications [patent_app_type] => utility [patent_app_number] => 16/109119 [patent_app_country] => US [patent_app_date] => 2018-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 48 [patent_no_of_words] => 18924 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109119 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/109119
Peptide hydrogel properties and its applications Aug 21, 2018 Issued
Array ( [id] => 17385587 [patent_doc_number] => 20220033439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => PEPTIDE TARGETING MYCOBACTERIUM TUBERCULOSIS TOXIN-ANTITOXIN SYSTEM AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/632867 [patent_app_country] => US [patent_app_date] => 2018-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6670 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632867 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/632867
PEPTIDE TARGETING MYCOBACTERIUM TUBERCULOSIS TOXIN-ANTITOXIN SYSTEM AND USE THEREOF Jul 30, 2018 Abandoned
Menu